GILEAD SCIENCES, INC. Q1 2025 Filing
Filed May 13, 2025
Portfolio Value
$1.2T
Holdings
14
Report Date
Q1 2025
Filing Type
13F-HR
All Holdings (14 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | ACLXARCELLX INC | 6,720,803 | $440.9B | 37.32% | |
| 2 | GLPGGALAPAGOS NV | 16,707,477 | $419.4B | 35.50% | |
| 3 | RCUSARCUS BIOSCIENCES INC | 31,424,760 | $246.7B | 20.88% | |
| 4 | ASMBASSEMBLY BIOSCIENCES INC | 2,209,471 | $21.1B | 1.79% | |
| 5 | MRUSMERUS N V | 452,527 | $19.0B | 1.61% | |
| 6 | KYTXKYVERNA THERAPEUTICS INC | 4,126,119 | $8.0B | 0.67% | |
| 7 | TNGXTANGO THERAPEUTICS INC | 4,854,443 | $6.7B | 0.56% | |
| 8 | XLOXILIO THERAPEUTICS INC | 9,105,451 | $6.6B | 0.56% | |
| 9 | KLRSKALARIS THERAPEUTICS INC | 723,273 | $5.8B | 0.49% | |
| 10 | HOOKHOOKIPA PHARMA INC | 1,875,945 | $2.0B | 0.17% | |
| 11 | ALLOALLOGENE THERAPEUTICS INC | 1,156,689 | $1.7B | 0.14% | |
| 12 | CYPHLEAP THERAPEUTICS INC | 5,319,148 | $1.6B | 0.14% | |
| 13 | —IKENA ONCOLOGY INC | 1,159,145 | $1.5B | 0.13% | |
| 14 | BRNSBARINTHUS BIOTHERAPEUTICS PL | 369,855 | $359.8M | 0.03% |